Sort
50,496 grants matching “lung cancer”
NIH Hematology Oncology Fellowship Program
$1,516,427Marijo Bilusic · Division Of Basic Sciences - Nci · ZIE · FY2019 · CA
Cancer Immunotherapy Clinical Trials
$1,516,058Julius Strauss · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
PLCO Trial Etiologic and Early Marker Study
$1,515,875Neal Freedman · Division Of Cancer Epidemiology And Genetics · ZIA · FY2021 · CA
Cancer Risk and Environmental Exposures to Nitrate, Pesticides, and IndustrialCh
$1,515,624Mary H Ward · Division Of Cancer Epidemiology And Genetics · Z01 · FY2008 · CA
Molecular Therapeutics of Kidney Cancer: MET Gene and BHD Gene
$1,514,792William Marston Linehan · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Cytokines and T Cell Development
$1,514,192Scott Durum · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Recipient Epidemiology and Donor Evaluation Study III (REDS-III) Domestic Hub
$1,514,116Mark Giaquinto · Institute For Transfusion Medicine · N01 · FY2011 · HL
Heriditary Neurodegenerative Storage Disorders
$1,513,758Anil B Mukherjee · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2011 · HD
Multiscale Analysis of Immune Responses
$1,513,316Ronald Germain · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Biological mechanisms involved with PDT in the treatment of MPM
$1,512,572Eli J Glatstein · University Of Pennsylvania · P01 · FY2015 · CA
Biological And Biochemical Characterization Of Sigma Receptors
$1,511,954Tsung-Ping Ping Su · National Institute On Drug Abuse · ZIA · FY2022 · DA
Chemoprevention of arsenic-induced skin cancer
$1,511,506Habibul Ahsan · University Of Chicago · R01 · FY2008 · CA
(2/3) MMC, VICC, and TSU: Partners in Eliminating Cancer Disparities
$1,511,193Tuya Pal · Vanderbilt University Medical Center · U54 · FY2022 · CA
Use of the Src Family Kinase Inhibitor Saracatinib in the Treatment of Pulmonary Fibrosis
$1,511,058Gregory Paul Downey · National Jewish Health · UH3 · FY2021 · TR
The connection of innate and adaptive anti-cancer immunity
$1,510,560John Greiner · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Genetic Susceptibility and Biomarkers of Platinum-related Toxicities
$1,510,356Lois B. Travis · University Of Rochester · R01 · FY2012 · CA
Center for Appalachian Research in Environmental Sciences
$1,508,940Erin N Haynes · University Of Kentucky · P30 · FY2024 · ES
Preventing Pneuomothorax During Transthoracic Lung Biopsy
$1,508,738Stephen Harry Spiegelberg · Cambridge Polymer Group, Inc. · R44 · FY2023 · CA
Molecular Toxicology of DNA Adducts
$1,507,845Arthur P Grollman · State University New York Stony Brook · P01 · FY2007 · ES
(2/3) MMC, VICC, and TSU: Partners in Eliminating Cancer Disparities
$1,507,811Tuya Pal · Vanderbilt University Medical Center · U54 · FY2024 · CA
Optical Systems for In Vivo Molecular Imaging of Cancer
$1,507,734Rebecca Rae Richards-Kortum · Rice University · R01 · FY2006 · CA
Molecular Analysis Of Human Hereditary Deafness
$1,507,148Andrew J. Griffith · National Institute On Deafness And Other Communication Disorders · ZIA · FY2009 · DC
University of Arizona Cancer Prevention Clinical Trials Network (UA CP-CTNet)
$1,507,039H-H. Sherry Chow · University Of Arizona · UG1 · FY2023 · CA
Research Capacity Core
$1,506,571Yanyuan Wu · Charles R. Drew University Of Med & Sci · U54 · FY2024 · MD
Immunotherapy for Malignant Mesothelioma, Lung Cancer and Thymic Malignancies
$1,506,569Raffit Hassan · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA